Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells

A high-throughput screen (HTS) was conducted against stably propagated cancer stem cell (CSC)-enriched populations using a library of 300,718 compounds from the National Institutes of Health (NIH) Molecular Libraries Small Molecule Repository (MLSMR). A cinnamide analog displayed greater than 20-fold selective inhibition of the breast CSC-like cell line (HMLE_sh_Ecad) over the isogenic control cell line (HMLE_sh_eGFP). Herein, we report structure–activity relationships of this class of cinnamides for selective lethality towards CSC-enriched populations.

Figure optionsDownload as PowerPoint slide